Excellence Awards – Shortlists Announced

The shortlist categories are divided into FOUR groups:

Excellence Categories – These categories look at achievements in our  core areas of excellence and include everything from Covid-19 Response to Social Impact.

Sector Excellence – These categories look at achievements within each individual market sub-sector and can include everything from notable business expansion through innovation to diversity and environmental initiatives.

Firms of the Year – These categories look at achievements by specific types of companies and includes everything from new market entrants to finance and legal firms.

Deals of the Year – The most notable finance and M&A deals from the research period.

 

*Please note that we also have awards for individuals, the winners of which will be announced in our Awards Report alongside the other category winners

Excellence Categories

BUSINESS EXPANSION

• Ajinomoto Bio-Pharma
• Arcus Biosciences, WuXi Biologics
• Dot Compliance
• Eli Lilly, Biologics
• Excellims
• GlaxoSmithKline (GSK)
• Nexus
• Regeneron
• Samsung Biologics
• Takeda
• UCB, Microsoft

COVID-19 RESPONSE

• Altimmune, DynPort
• Bharat Biotech, Ocugen
• CureVac
• Destiny Pharma, SporeGen
• Dynavax, Medigen
• GlaxoSmithKline (GSK)
• Intravacc, Celonic
• Medicago
• Moderna
• Novartis, Molecular Partners
• Oramed
• Roche, Regeneron
• SK, Novavax
• Symvivo
• Takeda
• T-scan

ENVIRONMENTAL IMPACT

• Alliance to Zero
• Lloyd
• The Sustainable Healthcare Coalition

INNOVATION

• Exscientia, BMS
• GlaxoSmithKline (GSK)
• Nvidia
• Piezo Motion
• University of California, San Diego
• University of California, Berkeley

PRODUCT LAUNCH

• Chief.AI
• Dot Compliance
• Genoskin
• Hetero
• Idifarma
• Indivior
• Merck

RESEARCH AND DEVELOPMENT

• Adagio Therapeutics
• Ampio
• BioMarin, Deep Genomics
• Codiak, Sarepta
• CRUK, Teon
• Oxford University
• Pfizer, BioNTech
• Scancell

SAFETY

• ArisGlobal
• TransPerfect

SOCIAL IMPACT

• The Altrui Foundation
• Galt Pharmaceuticals
• NGM Biopharmaceuticals
• Oximio

Sector Excellence

CARDIOVASCULAR

• Abbott
• AstraZeneca
• Humacyte

CENTRAL NERVOUS SYSTEM

• AbbVie, Caraway
• Biogen, Denali
• Eli Lilly, Verge Genomics
• Exscientia, Blue Oak
• GlaxoSmithKline (GSK), Alector
• Ipsen, Exicure
• Janssen
• PTC Therapeutics
• Roche, UCB

CLINICAL TRIALS

• AbbVie, Calico
• CytoDyn, Biomm
• Gilead, Novo Nordisk
• Hoth Therapeutics, UCRI
• Moderna
• Novavax
• Pfizer, BioNTech

DRUG DEVELOPMENT

• Arcus Biosciences, WuXi Biologics
• Arrowhead, Horizon
• BioMarin
• FUJIFILM Cellular Dynamics
• GI Innovation
• insitro
• IQVIA
• Merck
• Roivant Sciences
• UCB, Microsoft
• Viking Therapeutics

IMMUNOLOGY

• Amgen, Kyowa Kirin
• Biogen, В Bio-Thera
• Lilly, Rigel

INFECTIOUS DISEASES

• Exscientia
• Gilead Sciences
• Halozyme, ViiV Healthcare
• Takeda, Frazier
• Vaxart, Altesa

MANUFACTURING

• Amgen
• BioNTech, Novartis
• Cellares, Poseida Therapeutics
• Eisai, Seikagaku
• Irisys
• Moderna, Lonza
• Regeneron
• Samsung Biologics
• Sandoz
• Takeda
• Thermo Fisher Scientific
• VIVEbiotech
• WuXi AppTec, OXGENE

ONCOLOGY

• AbbVie, I-Mab
• Arcus Biosciences, WuXi Biologics
• AstraZeneca, Daiichi Sankyo
• Bayer, Triumvira Immunologics
• Bristol-Myers Squibb (BMS), Agenus
• Boehringer, Enara Bio
• Byondis, Glycotope
• CRUK, Teon
• Eisai, BMS
• Gilead, Tango Therapeutics
• HiFiBiO
• Revitope Oncology
• Pfizer
• Rhizen, Curon
• Twist, Neogene
• Umoja Biopharma

RESPIRATORY

• Icosavax
• Moderna
• Partner Therapeutics
• Pieris, Genentech
• Verona

SUPPLY CHAIN

• CalAmp
• Merck, BioNTech
• USP

Firm of the Year

DISRUPTOR

• Beam Therapeutics
• BeiGene
• Blueprint Medicines
• ClouDr
• Exscientia
• Five Prime Therapeutics
• GI Innovation
• Insitro
• Nvidia
• Zymergen

FINANCE

• Bank of America
• Barclays
• Centerview Partners
• Citigroup
• Cowen
• Evercore
• Guggenheim Partners
• JPMorgan Chase & Co/J.P. Morgan Securities
• Jefferies
• Lazard
• Morgan Stanley
• The Goldman Sachs Group

LEGAL

• Allen & Overy
• Cooley
• Cravath, Swaine & Moore
• Davis Polk & Wardwell
• Freshfields Bruckhaus Deringer
• Fried, Frank, Harris, Shriver & Jacobson
• Goodwin Procter
• Kirkland & Ellis
• Latham & Watkins
• Ropes & Gray
• Simpson Thacher & Bartlett
• Wachtell, Lipton, Rosen & Katz

NEWCOMER

• Alphazyme
• Beam Therapeutics
• Insitro
• Recursion Pharmaceuticals
• Relay Therapeutics

PRIVATE EQUITY/VC

• Bain Capital
• BC Partners
• EQT Partners
• Hellman & Friedman
• Pamplona Capital Management
• Partners Group
• Permira
• The Blackstone Group
• The Carlyle Group

SME

• Beam Therapeutics
• Five Prime Therapeutics
• GI Innovation
• Insitro
• Revitope Oncology
• Unchained Labs
• Viking Therapeutics

Deal of the Year

FINANCE

• Biomat
• Everest Med
• Hepalink
• Legend Bio
• Relay Tx
• Remegen
• Simcere
• Sotera Health

M&A (impact)

• AstraZeneca acquires Alexion
• Danaher acquires Aldevron
• Gilead Sciences acquires Immunomedics
• Horizon acquires Viela Bio
• Eli Lilly acquires Prevail Therapeutics
• Merck & Co. acquires VelosBio
• Nestlé acquires Aimmune Therapeutics
• PerkinElmer acquires BioLegend
• Thermo Fisher Scientific acquires PPD